Analytical Data
-
Gene name
HEAB
- Application
-
Alternative Names
CLP1. HEAB
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q92989
-
Expression Region
1-425aa
-
AA Sequence
MGEEANDDKKPTTKFELERETELRFEVEASQSVQLELLTGMAEIFGTELTRNKKFTFDAGAKVAVFTWHGCSVQLSGRTEVAYVSKDTPMLLYLNTHTALEQMRRQAEKEEERGPRVMVVGPTDVGKSTVCRLLLNYAVRLGRRPTYVELDVGQGSVSIPGTMGALYIERPADVEEGFSIQAPLVYHFGSTTPGTNIKLYNKITSRLADVFNQRCEVNRRASVSGCVINTCGWVKGSGYQALVHAASAFEVDVVVVLDQERLYNELKRDLPHFVRTVLLPKSGGVVERSKDFRRECRDERIREYFYGFRGCFYPHAFNVKFSDVKIYKVGAPTIPDSCLPLGMSQEDNQLKLVPVTPGRDMVHHLLSVSTAEGTEENLSETSVAGFIVVTSVDLEHQVFTVLSPAPRPLPKNFLLIMDIRFMDLK
-
Molecular Weight
74 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HEAB (Human Epidermal Antigen-Binding Protein) is a significant molecule that has garnered attention in the field of molecular biology and biotechnology due to its potential roles in various pathological conditions, particularly in cancer and autoimmune diseases. Studies have suggested that HEAB may be involved in the regulation of immune responses and cell signaling pathways, influencing tumor growth and metastasis. The recombinant production of HEAB in heterologous systems, such as bacteria or yeast, presents an opportunity to explore its functional properties more effectively, enabling researchers to study its structure-function relationships and therapeutic implications. Understanding HEAB's mechanisms of action at a molecular level could provide insights into developing novel diagnostic and therapeutic strategies. Moreover, recombinant HEAB could serve as a valuable tool for vaccine development and as a research reagent in immunology. The increasing interest in biopharmaceuticals emphasizes the need to characterize HEAB thoroughly, paving the way for potential applications in targeted therapies and personalized medicine. As research progresses, the role of HEAB in human health and disease may become clearer, underscoring its importance in biomedical research and therapeutic innovation.
